Literature DB >> 26958838

Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.

David M Thal1, Bingfa Sun2, Dan Feng2, Vindhya Nawaratne1, Katie Leach1, Christian C Felder3, Mark G Bures4, David A Evans5, William I Weis6,7, Priti Bachhawat2, Tong Sun Kobilka2, Patrick M Sexton1, Brian K Kobilka2,6, Arthur Christopoulos1.   

Abstract

Muscarinic M1-M5 acetylcholine receptors are G-protein-coupled receptors that regulate many vital functions of the central and peripheral nervous systems. In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurological disorders, such as Alzheimer's disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors. Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium. Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family. We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26958838      PMCID: PMC4915387          DOI: 10.1038/nature17188

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

Review 1.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

2.  Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation.

Authors:  Marco Scarselli; Bo Li; Soo-Kyung Kim; Jürgen Wess
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

3.  Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor.

Authors:  Christofer S Tautermann; Tobias Kiechle; Daniel Seeliger; Sonja Diehl; Eva Wex; Rolf Banholzer; Florian Gantner; Michael P Pieper; Paola Casarosa
Journal:  J Med Chem       Date:  2013-10-25       Impact factor: 7.446

Review 4.  Muscarinic acetylcholine receptors: novel opportunities for drug development.

Authors:  Andrew C Kruse; Brian K Kobilka; Dinesh Gautam; Patrick M Sexton; Arthur Christopoulos; Jürgen Wess
Journal:  Nat Rev Drug Discov       Date:  2014-06-06       Impact factor: 84.694

5.  Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

Authors:  A L Gnagey; M Seidenberg; J Ellis
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

Review 6.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Authors:  Jürgen Wess; Richard M Eglen; Dinesh Gautam
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 8.  Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Carrie K Jones; Craig W Lindsley
Journal:  Trends Pharmacol Sci       Date:  2009-02-07       Impact factor: 14.819

9.  ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures.

Authors:  Meytal Landau; Itay Mayrose; Yossi Rosenberg; Fabian Glaser; Eric Martz; Tal Pupko; Nir Ben-Tal
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

10.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  102 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  Expression and Preparation of a G-Protein-Coupled Cannabinoid Receptor CB2 for NMR Structural Studies.

Authors:  Alexei Yeliseev
Journal:  Curr Protoc Protein Sci       Date:  2019-01-09

3.  G protein-coupled receptors: the evolution of structural insight.

Authors:  Samantha B Gacasan; Daniel L Baker; Abby L Parrill
Journal:  AIMS Biophys       Date:  2017-08-21

4.  Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1.

Authors:  Tetsuya Hori; Toshiaki Okuno; Kunio Hirata; Keitaro Yamashita; Yoshiaki Kawano; Masaki Yamamoto; Masakatsu Hato; Motonao Nakamura; Takao Shimizu; Takehiko Yokomizo; Masashi Miyano; Shigeyuki Yokoyama
Journal:  Nat Chem Biol       Date:  2018-01-08       Impact factor: 15.040

5.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 6.  Allostery at opioid receptors: modulation with small molecule ligands.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

7.  A Novel Voltage Sensor in the Orthosteric Binding Site of the M2 Muscarinic Receptor.

Authors:  Ofra Barchad-Avitzur; Michael F Priest; Noa Dekel; Francisco Bezanilla; Hanna Parnas; Yair Ben-Chaim
Journal:  Biophys J       Date:  2016-10-04       Impact factor: 4.033

8.  Benchmarking GPCR homology model template selection in combination with de novo loop generation.

Authors:  Gregory L Szwabowski; Paige N Castleman; Chandler K Sears; Lee H Wink; Judith A Cole; Daniel L Baker; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2020-07-31       Impact factor: 3.686

9.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

10.  Autoantibodies Blocking M3 Muscarinic Receptors Cause Postganglionic Cholinergic Dysautonomia.

Authors:  Jose-Alberto Palma; Achla Gupta; Salvador Sierra; Ivone Gomes; Bhumika Balgobin; Lucy Norcliffe-Kaufmann; Lakshmi A Devi; Horacio Kaufmann
Journal:  Ann Neurol       Date:  2020-09-10       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.